Man asks ChatGPT for advice on how to cut salt, ends up in hospital with hallucinations
'However, when we asked ChatGPT 3.5 what chloride can be replaced with, we also produced a response that included bromide. Though the reply stated that context matters, it did not provide a specific health warning, nor did it inquire about why we wanted to know, as we presume a medical professional would do.'
Article content
The man already followed a very restrictive diet, one that doctors found was impacting his levels of important micronutrients, like vitamin C and B12. He was also reportedly very thirsty, but at the same time very worried about the quality of the water he was being offered, since he distilled his own water. He was thoroughly tested and first kept at the hospital for electrolyte monitoring and repletion.
Article content
His test results, combined with the hallucinations, and other reported symptoms, including new facial acne, fatigue and insomnia, led the medical staff to believe the patient had bromism.
Article content
Article content
Bromism, a condition that was mostly reported in the early 20th century, is caused by ingesting high quantities of sodium bromide. The normal levels of bromide are between 0.9 to 7.3 mg/L, but this patient had 1,700 mg/L.
Article content
The patient remained in the hospital for treatment for three weeks, and was stable at his check-up two weeks after his discharge.
Article content
Bromism cases decreased after the U.S. Food and Drug Administration (FDA) eliminated the use of bromide in the 1980s, the authors wrote. It was previously used in treatments for insomnia, hysteria and anxiety. However, the disease has reemerged now, with bromide being added to some unregulated dietary supplements and sedatives and the consumption of excess dextromethorphan, a substance included in cough medicine.
Article content
'While cases of bromism may remain relatively rare, it remains prudent to highlight bromism as a reversible cause of new-onset psychiatric, neurologic, and dermatologic symptoms, as bromide-containing substances have become more readily available with widespread use of the internet,' the authors wrote.
Article content
Article content
The doctors said that AI tools can be great for creating a bridge between scientists and the general population, but it also carries a risk of producing misinformation and giving information out of context, something that doctors are trained not to do.
Article content
'As the use of AI tools increases, providers will need to consider this when screening for where their patients are consuming health information,' the authors said in the case study.
Article content
OpenAI, the company that created ChatGPT, recently announced changes to their system, including being more careful when it comes to health-related questions. In one of the examples, the chatbot gives information but also includes a note about checking in with a health professional.
Article content
'Our terms say that ChatGPT is not intended for use in the treatment of any health condition, and is not a substitute for professional advice. We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance,' OpenAI said in a statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 hours ago
- Cision Canada
Triojection® from SpinaFX Granted Breakthrough Device Designation by U.S. FDA for Minimally Invasive Lumbar Disc Treatment
TORONTO, Aug. 15, 2025 /CNW/ - SpinaFX Medical Inc., ("SpinaFX") a leading innovator in image-guided interventional spine care, is proud to announce that its flagship device, Triojection®, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This milestone acknowledges Triojection's potential to offer a highly effective, more accessible, and safer treatment for patients suffering from contained lumbar disc herniations, a condition recognized as one of the most common causes of disability worldwide. The Breakthrough Devices Program is designed to expedite the development and review of medical devices that demonstrate clear advantages over existing technologies for serious or life-threatening conditions. This designation grants SpinaFX prioritized access to the FDA, fostering a collaborative approach to regulatory processes and accelerating the path toward commercialization and clinical availability. A Technological Leap in Spine Care Triojection is a minimally invasive, image-guided procedure that leverages a proprietary oxygen-ozone delivery system to reduce pressure within the disc and alleviate nerve compression. Unlike more invasive surgical approaches or prolonged conservative treatments that may fail to provide relief, Triojection offers a targeted, outpatient solution that can be performed in a variety of healthcare settings from hospitals and ambulatory surgical centers to clinics in emerging markets. The device meets the FDA's stringent Breakthrough criteria: Providing a unique, novel and more effective treatment for patients with contained disc herniations. Representing a true technological innovation in the spinal care landscape. Demonstrating significant advantages in terms of safety, recovery time, cost, and accessibility. Showing strong potential to improve outcomes across diverse economic and geographic contexts, including under-resourced health systems. Meeting an Urgent Global Need Lumbar disc herniation affects millions of people globally and is a leading contributor to chronic pain, loss of mobility, reduced productivity, and diminished quality of life. Existing treatments often fall into two extremes: conservative care, which may not always bring relief, or invasive surgery, which carries risks, high costs, and extended recovery times. Triojection fills a critical therapeutic gap. It offers an evidence-based, low-barrier, cost-effective alternative that can be deployed rapidly and with minimal infrastructure ideal for both advanced and developing market health systems. "Our mission is to transform spine care and make meaningful minimalist solutions accessible to all," said Prof. Kieran Murphy MD, Chairman, Founder and Chief Medical Officer at SpinaFX. "This designation by the FDA validates the scientific merit of Triojection and 21 years of work by many people who have helped get us to this point. It's a vote of confidence in the future of inventiveness in spine health. We sincerely thank all our investors for their support and trust." Backed by Global Expertise and Scientific Rigor This regulatory milestone is the result of over two decades of research and development, including multiple international studies and collaborations with leading clinical experts in Italy, Switzerland, Greece, the United States and Canada. SpinaFX acknowledges the contributions of its diverse network of engineers and investigators, including Prof. Mario Muto (Italy) and Prof. Alexis Kelekis (Greece), both pioneers in the field of Interventional Neuroradiology. Clinical data supporting Triojection's efficacy continues to build, with upcoming publications expected to highlight its outcomes across multicenter trials. The company's engineering, regulatory, and clinical affairs teams along with trusted partners across Europe and the United States have played a critical role in advancing the technology toward approval and adoption. A Platform for Future Innovation Beyond this first indication, SpinaFX is exploring additional applications of its oxygen-ozone delivery platform in treating other disc-related conditions and musculoskeletal disorders. The company is also expanding its educational programs to train physicians in safe, effective, and evidence-based use of the Triojection procedure. "Our team is honored to receive this designation, but we view it as just the beginning," said Jeff Cambra, CEO of SpinaFX. "We're committed to working hand-in-hand with the FDA to bring Triojection to patients in the U.S. and beyond. Our goal is to create a new standard in spine care that's efficient, scalable, and deeply patient-centered. " About SpinaFX SpinaFX Medical Inc. is a Canadian-based medical technology company specializing in minimally invasive, image-guided therapies for spinal disorders. Its proprietary technology platform offers non-surgical solutions for treating disc-related conditions, using a unique approach to oxygen-ozone therapy. Committed to democratizing access to advanced spine care, SpinaFX collaborates with leading academic institutions, clinicians, and healthcare providers across the globe. Forward-Looking Statement This news release contains predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance, referred to herein as "forward-looking statements", which are made as of the date of this news release or as of the effective date of information described in this release, as applicable. The forward-looking statements address anticipated events or occurrences which may include economic factors, industry trends, market demand, and corporate performance and profitability, that may have an impact on SpinaFX's success. Forward-looking statements are often identified through words or expressions including "expects", "anticipates", "plans", "projects", "estimates", "envisages", "assumes", "intends", "strategy", "goals", "objectives" or variations thereof or stating that certain actions, events or results "may", "can", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative of any of these terms and similar expressions. All forward-looking statements are based on current beliefs as well as various assumptions made by, and information currently available to SpinaFX's management team. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, projections, and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. We caution any person reviewing this news release not to place undue reliance on these forward-looking statements as several important factors could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates, assumptions and intentions expressed in such forward-looking statements. Neither SpinaFX nor its representatives undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by SpinaFX or its representatives or on behalf of either of them, except as may be required by law.
Ottawa Citizen
18 hours ago
- Ottawa Citizen
Man asks ChatGPT for advice on how to cut salt, ends up in hospital with hallucinations
Article content 'However, when we asked ChatGPT 3.5 what chloride can be replaced with, we also produced a response that included bromide. Though the reply stated that context matters, it did not provide a specific health warning, nor did it inquire about why we wanted to know, as we presume a medical professional would do.' Article content The man already followed a very restrictive diet, one that doctors found was impacting his levels of important micronutrients, like vitamin C and B12. He was also reportedly very thirsty, but at the same time very worried about the quality of the water he was being offered, since he distilled his own water. He was thoroughly tested and first kept at the hospital for electrolyte monitoring and repletion. Article content His test results, combined with the hallucinations, and other reported symptoms, including new facial acne, fatigue and insomnia, led the medical staff to believe the patient had bromism. Article content Article content Bromism, a condition that was mostly reported in the early 20th century, is caused by ingesting high quantities of sodium bromide. The normal levels of bromide are between 0.9 to 7.3 mg/L, but this patient had 1,700 mg/L. Article content The patient remained in the hospital for treatment for three weeks, and was stable at his check-up two weeks after his discharge. Article content Bromism cases decreased after the U.S. Food and Drug Administration (FDA) eliminated the use of bromide in the 1980s, the authors wrote. It was previously used in treatments for insomnia, hysteria and anxiety. However, the disease has reemerged now, with bromide being added to some unregulated dietary supplements and sedatives and the consumption of excess dextromethorphan, a substance included in cough medicine. Article content 'While cases of bromism may remain relatively rare, it remains prudent to highlight bromism as a reversible cause of new-onset psychiatric, neurologic, and dermatologic symptoms, as bromide-containing substances have become more readily available with widespread use of the internet,' the authors wrote. Article content Article content The doctors said that AI tools can be great for creating a bridge between scientists and the general population, but it also carries a risk of producing misinformation and giving information out of context, something that doctors are trained not to do. Article content 'As the use of AI tools increases, providers will need to consider this when screening for where their patients are consuming health information,' the authors said in the case study. Article content OpenAI, the company that created ChatGPT, recently announced changes to their system, including being more careful when it comes to health-related questions. In one of the examples, the chatbot gives information but also includes a note about checking in with a health professional. Article content In response to the bromide case, OpenAI told Fox News Digital that no one should be using ChatGPT for health advice. Article content 'Our terms say that ChatGPT is not intended for use in the treatment of any health condition, and is not a substitute for professional advice. We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance,' OpenAI said in a statement.
Calgary Herald
19 hours ago
- Calgary Herald
Man asks ChatGPT for advice on how to cut salt, ends up in hospital with hallucinations
Article content 'However, when we asked ChatGPT 3.5 what chloride can be replaced with, we also produced a response that included bromide. Though the reply stated that context matters, it did not provide a specific health warning, nor did it inquire about why we wanted to know, as we presume a medical professional would do.' Article content The man already followed a very restrictive diet, one that doctors found was impacting his levels of important micronutrients, like vitamin C and B12. He was also reportedly very thirsty, but at the same time very worried about the quality of the water he was being offered, since he distilled his own water. He was thoroughly tested and first kept at the hospital for electrolyte monitoring and repletion. Article content His test results, combined with the hallucinations, and other reported symptoms, including new facial acne, fatigue and insomnia, led the medical staff to believe the patient had bromism. Article content Article content Bromism, a condition that was mostly reported in the early 20th century, is caused by ingesting high quantities of sodium bromide. The normal levels of bromide are between 0.9 to 7.3 mg/L, but this patient had 1,700 mg/L. Article content The patient remained in the hospital for treatment for three weeks, and was stable at his check-up two weeks after his discharge. Article content Bromism cases decreased after the U.S. Food and Drug Administration (FDA) eliminated the use of bromide in the 1980s, the authors wrote. It was previously used in treatments for insomnia, hysteria and anxiety. However, the disease has reemerged now, with bromide being added to some unregulated dietary supplements and sedatives and the consumption of excess dextromethorphan, a substance included in cough medicine. Article content 'While cases of bromism may remain relatively rare, it remains prudent to highlight bromism as a reversible cause of new-onset psychiatric, neurologic, and dermatologic symptoms, as bromide-containing substances have become more readily available with widespread use of the internet,' the authors wrote. Article content Article content The doctors said that AI tools can be great for creating a bridge between scientists and the general population, but it also carries a risk of producing misinformation and giving information out of context, something that doctors are trained not to do. Article content 'As the use of AI tools increases, providers will need to consider this when screening for where their patients are consuming health information,' the authors said in the case study. Article content OpenAI, the company that created ChatGPT, recently announced changes to their system, including being more careful when it comes to health-related questions. In one of the examples, the chatbot gives information but also includes a note about checking in with a health professional. Article content 'Our terms say that ChatGPT is not intended for use in the treatment of any health condition, and is not a substitute for professional advice. We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance,' OpenAI said in a statement.
